A multi-center, randomized controlled trial for 'Jia-Wei Si-Ni' decoction in the treatment of ischemic apoplexy based on multi-histology integration strategy

Phase 1

Recruiting

• Conditions: ischemic stroke

• Registration Number: ITMCTR1900002351
• Lead Sponsor: The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

(1) ischemic stroke patients with a course of 2-4 weeks;
(2) aged between 18 and 80 years;
(3) meet the diagnostic criteria of cerebral infarction in the guidelines for the diagnosis and treatment of cerebral infarction in China (2017);
(4) ischemic stroke that meets the diagnostic criteria of Yang deficiency in traditional Chinese medicine;
(5) the patient is conscious;
(6) the patient agreed to accept the project and signed the informed consent.

Exclusion Criteria

(1) patients with severe heart disease, active liver disease, cardiac insufficiency, renal insufficiency, respiratory failure, malignant tumor and gastrointestinal bleeding may not be able to complete the follow-up;
(2) patients with mental illness and deaf-mutes, who have a history of dementia;
(3) pregnant and lactating women;
(4) patients participating in other clinical trials;
(5) patients who are not suitable for clinical trials according to other reasons.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The recurrence rate of ischemic stroke at 90 days;

Secondary Outcome Measures

Name	Time	Method
Recurrence rate in hospital and 30 days after discharge;